2MBZ

Structural Basis of a Thiopeptide Antibiotic Multidrug Resistance System from Streptomyces lividans:Promothiocin A in Complex with TipAS


SOLUTION NMR
NMR Experiment
ExperimentTypeSample ContentsSolventIonic StrengthpHPressureTemperature (K)Spectrometer
12D 1H-15N HSQC1 mM [U-98% 15N] TipAS-1, 2 mM promothiocin A-2, 50 mM potassium phosphate-3, 0.02 w/v sodium azide-495% H2O/5% D2O0.0555.9ambient298
22D 1H-13C HSQC aliphatic1 mM [U-100% 13C; U-100% 15N] TipAS-9, 2 mM promothiocin A-10, 50 mM potassium phosphate-11, 0.02 w/v sodium azide-12100% D2O0.0555.9ambient298
33D HNCO1 mM [U-100% 13C; U-100% 15N] TipAS-5, 2 mM promothiocin A-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-895% H2O/5% D2O0.0555.9ambient298
43D CBCA(CO)NH1 mM [U-100% 13C; U-100% 15N] TipAS-5, 2 mM promothiocin A-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-895% H2O/5% D2O0.0555.9ambient298
53D C(CO)NH TOCSY1 mM [U-100% 13C; U-100% 15N] TipAS-5, 2 mM promothiocin A-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-895% H2O/5% D2O0.0555.9ambient298
63D HBHA(CO)NH1 mM [U-100% 13C; U-100% 15N] TipAS-5, 2 mM promothiocin A-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-895% H2O/5% D2O0.0555.9ambient298
73D H(CCO)NH TOCSY1 mM [U-100% 13C; U-100% 15N] TipAS-5, 2 mM promothiocin A-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-895% H2O/5% D2O0.0555.9ambient298
83D HCCH-TOCSY aliphatic1 mM [U-100% 13C; U-100% 15N] TipAS-9, 2 mM promothiocin A-10, 50 mM potassium phosphate-11, 0.02 w/v sodium azide-12100% D2O0.0555.9ambient298
93D HNHA1 mM [U-100% 13C; U-100% 15N] TipAS-5, 2 mM promothiocin A-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-895% H2O/5% D2O0.0555.9ambient298
10HAHB1 mM [U-100% 13C; U-100% 15N] TipAS-9, 2 mM promothiocin A-10, 50 mM potassium phosphate-11, 0.02 w/v sodium azide-12100% D2O0.0555.9ambient298
11CBCANH1 mM [U-100% 13C; U-100% 15N] TipAS-5, 2 mM promothiocin A-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-895% H2O/5% D2O0.0555.9ambient298
1213C'-{13C } spin-echo difference 1H-15N HSQC1 mM [U-100% 13C; U-100% 15N] TipAS-5, 2 mM promothiocin A-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-895% H2O/5% D2O0.0555.9ambient298
1315N-{13C } spin-echo difference 1H-15N HSQC1 mM [U-100% 13C; U-100% 15N] TipAS-5, 2 mM promothiocin A-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-895% H2O/5% D2O0.0555.9ambient298
1413C'-{13C } spin-echo difference 1H-13C HSQC1 mM [U-100% 13C; U-100% 15N] TipAS-5, 2 mM promothiocin A-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-895% H2O/5% D2O0.0555.9ambient298
1515N-{13C } spin-echo difference 1H-13C HSQC1 mM [U-100% 13C; U-100% 15N] TipAS-5, 2 mM promothiocin A-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-895% H2O/5% D2O0.0555.9ambient298
163D 1H-15N ROESY1 mM [U-98% 15N] TipAS-1, 2 mM promothiocin A-2, 50 mM potassium phosphate-3, 0.02 w/v sodium azide-495% H2O/5% D2O0.0555.9ambient298
173D 1H-15N NOESY1 mM [U-98% 15N] TipAS-1, 2 mM promothiocin A-2, 50 mM potassium phosphate-3, 0.02 w/v sodium azide-495% H2O/5% D2O0.0555.9ambient298
183D 1H-13C NOESY1 mM [U-100% 13C; U-100% 15N] TipAS-9, 2 mM promothiocin A-10, 50 mM potassium phosphate-11, 0.02 w/v sodium azide-12100% D2O0.0555.9ambient298
194D 13C-13C-NOESY-HMQC1 mM [U-100% 13C; U-100% 15N] TipAS-9, 2 mM promothiocin A-10, 50 mM potassium phosphate-11, 0.02 w/v sodium azide-12100% D2O0.0555.9ambient298
202D NOESY filtered against 1H bound to 13C or 15N1 mM [U-100% 13C; U-100% 15N] TipAS-9, 2 mM promothiocin A-10, 50 mM potassium phosphate-11, 0.02 w/v sodium azide-12100% D2O0.0555.9ambient298
212D NOESY filtered against 1H bound to 13C or 15N1 mM [U-100% 13C; U-100% 15N] TipAS-5, 2 mM promothiocin A-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-895% H2O/5% D2O0.0555.9ambient298
222D HOHAHA filtered against 1H bound to 13C or 15N1 mM [U-100% 13C; U-100% 15N] TipAS-9, 2 mM promothiocin A-10, 50 mM potassium phosphate-11, 0.02 w/v sodium azide-12100% D2O0.0555.9ambient298
23Doublet-separated sensitivity-enhanced 1H-15N HSQC1 mM [U-100% 13C; U-100% 15N] TipAS-5, 2 mM promothiocin A-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-895% H2O/5% D2O0.0555.9ambient298
24Doublet-separated sensitivity-enhanced 1H-15N HSQC0.8 mM [U-100% 13C; U-100% 15N] TipAS-13, 1.6 mM promothiocin A-14, 10 mM potassium phosphate-15, 10 mg/mL Pf1 phage-1695% H2O/5% D2O0.0555.9ambient298
25J-resolved constant-time 13C-HSQC1 mM [U-100% 13C; U-100% 15N] TipAS-5, 2 mM promothiocin A-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-895% H2O/5% D2O0.0555.9ambient298
26J-resolved constant-time 13C-HSQC0.8 mM [U-100% 13C; U-100% 15N] TipAS-13, 1.6 mM promothiocin A-14, 10 mM potassium phosphate-15, 10 mg/mL Pf1 phage-1695% H2O/5% D2O0.0555.9ambient298
273D 1H-13C NOESY aromatic1 mM [U-100% 13C; U-100% 15N] TipAS-9, 2 mM promothiocin A-10, 50 mM potassium phosphate-11, 0.02 w/v sodium azide-12100% D2O0.0555.9ambient298
NMR Spectrometer Information
SpectrometerManufacturerModelField Strength
1BrukerDRX600
2BrukerDRX800
NMR Refinement
MethodDetailsSoftware
simulated annealing1st. simulated annealing step: ligand is covalently attached, but only restraints of the folded part of the protein in apo form are used 2nd. simulated annealing step: all restraints are usedX-PLOR NIH
NMR Ensemble Information
Conformer Selection Criteriastructures with the lowest energy
Conformers Calculated Total Number100
Conformers Submitted Total Number10
Representative Model1 (lowest energy)
Computation: NMR Software
#ClassificationVersionSoftware NameAuthor
1structure solutionX-PLOR NIH2.30Schwieters, Kuszewski, Tjandra and Clore
2refinementX-PLOR NIH2.30Schwieters, Kuszewski, Tjandra and Clore
3processingNMRPipe2012Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
4peak pickingSparky3.115Goddard
5chemical shift assignmentSparky3.115Goddard
6peak pickingPIPPGarrett
7chemical shift assignmentXEASYBartels et al.
8dihedral angle predictionTALOStalos+Cornilescu, Delaglio and Bax
9structure analysisProcheckNMRLaskowski and MacArthur
10experiment/data collectionXwinNMRBruker Biospin
11experiment/data collectionTopSpinBruker Biospin